BioAdaptives (BDPT) Aktie Kurs

BioAdaptives, Inc. is a research, development, marketing and educational company. The company is headquartered in Las Vegas, Nevada and currently employs 1 full-time employees. The company went IPO on 2014-07-09. The firm is focused on products for health and wellness. These products include dietary supplements, specialty food items, and methods of optimizing the bioelectromagnetic availability of foods and beverages. Its base of intellectual property and products, which are solutions in the form of devices and nutraceuticals, are designed to aid in cognition, focus, fatigue reduction, increased testosterone, improved overall emotional and physical wellness, healing, and anti-aging. The firm has a product agreement with Ferris Holding, Inc. (Ferris), pursuant to which it has the right to develop, market and sell the products, including PrimiCell and PrimiLive. Additionally, it has two products, which are in the advanced stage of testing: Equine Regen and Equine Regen Plus. The firm also offers PrimiTrim, which is a weight control product, and an exercise product. The company is also developing a product for dogs.